You may also like
Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass
Preclinical animal models used in this study showed that Ir-CPI is an effective and safe antithrombotic agent that provides a clinically relevant approach to thrombosis prevention in bypass systems, including highly thrombogenic CPB.
1 min read
Effect of Adenosine-Regulating Agent Acadesine on Morbidity and Mortality Associated with Coronary Artery Bypass Grafting: The RED-CABG Randomized Controlled Trial
Ischemia/reperfusion injury remains an important cause of morbidity and mortality after coronary artery bypass graft (CABG) surgery.
1 min read
Effect and Safety of 4% Albumin in the Treatment of Cardiac Surgery Patients: Study Protocol for the Randomized, Double-Blind, Clinical ALBICS (ALBumin In Cardiac Surgery) Trial
The findings of this study will provide new evidence regarding efficacy and safety of albumin solution in adult patients undergoing cardiac surgery with CPB.
1 min read